Diabetes, Vol 39, Issue 5 639-642, Copyright © 1990 by American Diabetes Association

ARTICLES

Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration

T Mitsukawa, J Takemura, J Asai, M Nakazato, K Kangawa, H Matsuo and S Matsukura
Third Department of Internal Medicine, Miyazaki Medical College, Japan.

We determined islet amyloid polypeptide (IAPP) response in plasma to oral and intravenous glucose administration and intravenous insulin injection in nondiabetic subjects. Moreover, we studied the effect of somatostatin analogue SMS 201-995 on glucose-induced IAPP secretion in nondiabetic subjects. Plasma IAPP concentration was determined by radioimmunoassay. Oral administration of 75 g glucose (n = 8) significantly increased plasma IAPP levels from 4.5 +/- 0.7 to 14.0 +/- 1.7 pM (P less than 0.01) 60 min after administration. Intravenous administration of 10 g glucose (n = 7) also caused a significant increase in plasma IAPP from 5.0 +/- 0.4 to 11.6 +/- 0.9 pM (P less than 0.01) 5 min after injection. Plasma IAPP significantly decreased from 5.1 +/- 0.4 to 2.9 +/- 0.4 pM (P less than 0.01) 60 min after intravenous insulin injection (n = 8). Pretreatment with SMS 201-995 completely abolished IAPP and insulin secretion to intravenous glucose injection. A significant correlation was found between plasma IAPP and insulin levels in oral and intravenous glucose administration and between plasma IAPP and C-peptide levels during insulin-induced hypoglycemia. These results suggest that IAPP is cosecreted with insulin in response to a glucose load and secretion of IAPP is inhibited by hypoglycemia and somatostatin. IAPP may serve as a novel pancreatic hormone to control carbohydrate metabolism.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				V Kairamkonda, A Deorukhkar, R Coombs, R Fraser, and T Mayer Amylin peptide levels are raised in infants of diabetic mothers Arch. Dis. Child., December 1, 2005; 90(12): 1279 - 1282. [Abstract] [Full Text] [PDF]

				R. A. Ritzel and P. C. Butler Replication Increases {beta}-Cell Vulnerability to Human Islet Amyloid Polypeptide-Induced Apoptosis Diabetes, July 1, 2003; 52(7): 1701 - 1708. [Abstract] [Full Text] [PDF]

				W.-Q. Ding, E. Holicky, and L. J. Miller Glucose and forskolin regulate IAPP gene expression through different signal transduction pathways Am J Physiol Endocrinol Metab, November 1, 2001; 281(5): E938 - E945. [Abstract] [Full Text] [PDF]

				M. Clodi, K. Thomaseth, G. Pacini, K. Hermann, A. Kautzky-Willer, W. Waldhausl, R. Prager, and B. Ludvik Distribution and kinetics of amylin in humans Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E903 - E908. [Abstract] [Full Text] [PDF]

				U. Arnelo, J. Permert, J. Larsson, R. D. Reidelberger, C. Arnelo, and T. E. Adrian Chronic Low Dose Islet Amyloid Polypeptide Infusion Reduces Food Intake, But Does Not Influence Glucose Metabolism, in Unrestrained Conscious Rats: Studies Using a Novel Aortic Catheterization Technique Endocrinology, October 1, 1997; 138(10): 4081 - 4085. [Abstract] [Full Text] [PDF]